TRPC6

Source: Wikipedia, the free encyclopedia.
TRPC6
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_004621

NM_001282086
NM_001282087
NM_013838

RefSeq (protein)

NP_004612

NP_001269015
NP_001269016
NP_038866

Location (UCSC)Chr 11: 101.45 – 101.87 MbChr 9: 8.54 – 8.68 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Transient receptor potential cation channel, subfamily C, member 6 or Transient receptor potential canonical 6, also known as TRPC6, is a human gene encoding a protein of the same name. TRPC6 is a transient receptor potential channel of the classical TRPC subfamily.[5]

TRPC6 channels are nonselective cation channels that respond directly to diacylglycerol (DAG), a product of phospholipase C activity. This activation leads to cellular depolarization and calcium influx.[5][6]

Unlike the closely related TRPC3 channels, TRPC6 channels possess the distinctive ability to transport heavy metal ions. TRPC6 channels facilitate the transport of zinc ions, promoting their accumulation inside cells.[6][7] In addition, despite their non-selectiveness, TRPC6 exhibits a strong preference for calcium ions, with a permeability ratio of calcium to sodium (PCa/PNa) of roughly six. This selectivity is significantly higher compared to TRPC3, which displays a weaker preference for calcium with a (PCa/PNa) ratio of only 1.1.[6]

Function

TRPC6 channels are widely distributed in the human body and are emerging as crucial regulators of several key physiological functions:

In blood vessels

Small arteries and

arterioles exhibit a self-regulatory mechanism called myogenic tone, enabling them to maintain relatively stable blood flow despite fluctuating intravascular pressures.[8] When intravascular pressure within a small artery or arteriole increases, the vessel walls automatically constrict. This narrowing reduces blood flow, effectively counteracting the rising pressure and stabilizing overall flow. Conversely, if blood pressure suddenly drops, vasodilation occurs to allow more blood flow and compensate for the decrease.[9]

TRPC6 channels are present both in endothelial and smooth muscle cells[8] and their function is similar to α‑adrenoreceptors; they are both involved in vasoconstriction.[9] However, TPRC6-mediated vasoconstriction is mechanosensetive (i.e. activated by mechanical stimulation) and these channels are involved in maintenance of the myogenic tone of blood vessels and autoregulation of blood flow.[8]

When intravascular blood pressure rises, this causes stretching of the walls of blood vessels. This mechanical stretch activates the TRPC6 channel. Once activated, TRPC6 allows Ca2+ to enter the smooth muscle cells. This increase in intracellular Ca2+ triggers a chain reaction leading to vasoconstriction.[6]

In the central nervous system

Research of learning and memory mechanisms suggests that a continuous increase in the strength of synaptic transmission is necessary to achieve long-term modification of neural network properties and memory storage. TRPC6 appears to be essential for the formation of an excitatory synapse; overexpressing TRPC6 greatly increased dendritic spine density and the level of synapsin I and PSD-95 cluster, known as the pre- and postsynaptic markers.[10]

TRPC6 has also been proven to participate in neuroprotection and its neuroprotective effect could be explained due to the antagonism of extrasynaptic NMDA receptor (NMDAR)-mediated intracellular calcium overload. TRPC6 activates calcineurin, which impedes the NMDAR activity.[10]

Hyperactivation of NMDAR is a critical event in

endonucleases, etc. This downstream neurotoxic cascade may trigger severe damage to neuronal functioning. Hyperactivation of NMDAR is frequently observed during brain ischemia and late stage Alzheimer's disease.[10]

In the kidneys

TRPC6 channels are extensively present throughout the kidney, both in the

podocytes.[11] Despite being extensively expressed throughout the kidneys and despite the established link between TRPC6 over-activation and kidney pathologies, the physiological roles of this channel in healthy kidney function remain less understood.[12][13] Podocytes normally display minimal baseline activity of TRPC6 channels and TRPC6 knockout mice have not shown any evident changes in glomerular structure or filtration.[12]

Clinical significance

Since TRPC6 channels play a multifaceted role by participating in various signaling pathways, these channels are emerging as key players in the pathogenesis of a wide range of diseases including:[14]

  1. Kidney diseases
  2. Disorders of the nervous system
  • Cancers
  • Cardiovascular diseases
  • Pulmonary diseases
    • Lung fibrosis
  • Interactions

    TRPC6 has been shown to

    interact
    with:

    Ligands

    Two of the primary

    binding to and activating TRPC6.[19][20] Recent results with hyperforin have cast doubt on these findings as similar currents are seen upon Hyperforin treatment regardless of the presence of TRPC6.[21]

    References

    1. ^ a b c GRCh38: Ensembl release 89: ENSG00000137672Ensembl, May 2017
    2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000031997Ensembl, May 2017
    3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
    4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
    5. ^
      PMID 29700422
      .
    6. ^ .
    7. .
    8. ^ .
    9. ^ .
    10. ^
      PMID 37895105. This article incorporates text available under the CC BY 4.0
      license.
    11. .
    12. ^ .
    13. .
    14. .
    15. .
    16. .
    17. .
    18. .
    19. ^ .
    20. .
    21. .

    Further reading

    External links


    This page is based on the copyrighted Wikipedia article: TRPC6. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy